N. Taguchi

发表

A Comparative Analysis of the Murine Thymic Microenvironment in Normal, Autoimmune, and Immunodeficiency States

K. Tsuneyama, M. Gershwin, L. Shultz, 1997, Developmental immunology.

Increased expression of mXBP-1 (TREB-5) in thymic B cells in New Zealand mice.

M. Gershwin, L. Shultz, K. Dorshkind, 2001, Journal of autoimmunity.

B cells are selectively associated with thymic cortical but not medullary pathology in NZB mice.

S. Ikehara, M. Gershwin, L. Shultz, 2001, Journal of autoimmunity.

Abnormal thymic expression of epithelial cell adhesion molecule (EP-CAM) in New Zealand Black (NZB) mice.

S. Ikehara, M. Gershwin, L. Shultz, 1999, Journal of autoimmunity.

NZB Mice Exhibit a Primary T Cell Defect in Fetal Thymic Organ Culture1

M. Gershwin, E. Montecino-Rodriguez, K. Dorshkind, 2000, The Journal of Immunology.

Identification and analysis of the Saccharomyces cerevisiae SYR1 gene reveals that ergosterol is involved in the action of syringomycin.

T. Miyakawa, J. Takemoto, Y. Wang, 1994, Microbiology.

Apoptosis and the thymic microenvironment in murine lupus.

M. Gershwin, L. Shultz, R. Boyd, 1999, Journal of autoimmunity.

Mechanism of action of the phytotoxin syringomycin : a resistant mutant of Saccharomyces cerevisiae reveals an involvement of Ca2+ transport

T. Miyakawa, J. Takemoto, Lei Zhang, 1991 .

2-Buten-4-olide (2-B4O) inhibits type II collagen-induced arthritis in Lewis rats.

M. Naiki, S. Suehiro, Y. Takeoka, 1993, International journal of immunopharmacology.

Thymic microenvironment and NZB mice: the abnormal thymic microenvironment of New Zealand mice correlates with immunopathology.

T. Vyse, M. Gershwin, L. Shultz, 1999, Clinical immunology.